Jinbo Yue

机构：Shandong Tumor Hospital, Wuhan No.1 Hospital, Shandong First Medical University · ORCID：0000-0002-5768-8622

发表论文 79 篇 · 总被引 1074 次 · h-index 18

代表论文

• CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial (2025 · Nature Medicine · 被引 40)
• [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma (2023 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 28)
• Deciphering tumor-infiltrating dendritic cells in the single-cell era (2023 · Experimental Hematology and Oncology · 被引 22)
• Safety and efficacy of IBI343 (anti-claudin18.2 antibody-drug conjugate) in patients with advanced pancreatic ductal adenocarcinoma or biliary tract cancer: Preliminary results from a phase 1 study. (2024 · Journal of Clinical Oncology · 被引 19)
• Consensus statement on the exploration of clinical translation and application of electron ultra‐high dose rate FLASH radiotherapy (2025 · Precision Radiation Oncology · 被引 13)
• Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy (2024 · Biomarker Research · 被引 12)